Previous studies have reported that BT474 human breast cancer cell growth increases in response to POGLUT1 overexpression due to POGLUT1-induced inhibition of transforming growth factor β1 (TGF-β1)-mediated induction of INK4a gene expression (7,8). This evidence concerns the gene CDKN2A and breast cancer.